Efficacy of combination therapy with pembrolizumab and axitinib for metastatic renal collecting duct cell carcinoma: A report on two cases

INTRODUCTION: Immunotherapy‐based combinations have become the standard first‐line therapy for metastatic renal cell carcinoma. However, combined immunotherapy for renal collecting duct carcinoma had been reported, but its therapeutic efficacy had been unclear. CASE PRESENTATION: The first case was...

Descripción completa

Detalles Bibliográficos
Autores principales: Tamada, Shinji, Ikarashi, Daiki, Tsuyukubo, Takashi, Iwasaki, Kazuhiro, Isurugi, Kazumasa, Ono, Sadahide, Takata, Ryo, Fujisawa, Hiromitsu, Obara, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626324/
https://www.ncbi.nlm.nih.gov/pubmed/36341193
http://dx.doi.org/10.1002/iju5.12504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626324/
https://www.ncbi.nlm.nih.gov/pubmed/36341193
http://dx.doi.org/10.1002/iju5.12504

Ejemplares similares